Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | ASND | ||
| Company | Genmab A/S ADR | Incyte Corp | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 28.05 | 97.02 | 235.00 | ||
| High | 28.23 | 98.19 | 235.00 | ||
| Low | 27.62 | 96.00 | 227.26 | ||
| Latest | 27.69 | 96.74 | 231.05 | ||
| Change | +0.63 | +0.52 | -9.24 | ||
| % Change | +2.33% | +0.54% | -3.85% | ||
| Volume | 1,861,400 | 1,012,600 | 1,809,500 | ||
| 20-Day Average Volume | 1,802,485 | 1,307,735 | 624,755 | ||
| Previous Close | 27.06 | 96.22 | 240.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.59 | 95.01 | 233.43 | ||
| 20-Day Raw Stochastic | 52.59% | 67.67% | 44.88% | ||
| 20-Day Relative Strength | 48.16 | 51.33 | 49.25 | ||
| Weighted Alpha | +23.76 | +49.20 | +38.15 | ||
| Today's Opinion | 56% Sell | 8% Buy | 88% Buy | ||
| Previous Opinion | 72% Sell | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 56% Sell | 24% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.49% since 04/15/26 | -0.37% since 04/15/26 | -4.41% since 04/15/26 | ||
| Low | 26.89 on 04/21/26 | 94.56 on 04/16/26 | 227.26 on 04/22/26 | ||
| High | 29.08 on 04/16/26 | 98.70 on 04/20/26 | 248.98 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +10.32% since 03/20/26 | +6.57% since 03/20/26 | +4.13% since 03/20/26 | ||
| Low | 25.42 on 03/24/26 | 89.25 on 03/24/26 | 212.60 on 03/24/26 | ||
| High | 29.43 on 04/14/26 | 99.92 on 04/15/26 | 250.74 on 04/13/26 | ||
| 3-Month | |||||
| %Chg | -16.34% since 01/22/26 | -7.92% since 01/22/26 | +1.05% since 01/22/26 | ||
| Low | 24.95 on 03/20/26 | 89.25 on 03/24/26 | 211.00 on 02/12/26 | ||
| High | 34.68 on 01/27/26 | 109.48 on 02/09/26 | 250.74 on 04/13/26 | ||
| 6-Month | |||||
| %Chg | -7.45% since 10/22/25 | +9.86% since 10/22/25 | +13.99% since 10/22/25 | ||
| Low | 24.95 on 03/20/26 | 84.02 on 10/28/25 | 188.07 on 11/13/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 250.74 on 04/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,386,240 | 19,149,128 | 14,988,566 | ||
| Shares Outstanding, K | 642,507 | 199,014 | 62,377 | ||
| Annual Sales | 3,720,000,000 | 5,141,240,000 | 814,760,000 | ||
| Annual Net Income | 963,000,000 | 1,286,650,000 | -258,000,000 | ||
| Last Quarter Sales | 1,058,000,000 | 1,506,840,000 | 279,270,000 | ||
| Last Quarter Net Income | 31,000,000 | 299,280,000 | -42,910,000 | ||
| 60-Month Beta | 0.97 | 0.85 | 0.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 02/17/26 | 1.80 on 02/10/26 | -0.64 on 02/11/26 | ||
| Latest Earnings Date | 05/14/26 | 04/28/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.01 | 16.74 | 0.00 | ||